Contact us
Log in
Dr. Guillaume Ploussard, MD, PhD
Personal info
Overview
Courses
Work Experience
Education
Pubmed
Professional Association|Professional Associations
Honors
Personal info
Specialty Urology
Place Toulouse, France
Overview

Guillaume Ploussard (MD, PhD) is working as uro-oncologist in Toulouse, France, at Saint-Jean Languedoc Hospital and Institut Universitaire du Cancer - Oncopole. After Medical School at the University of Paris, he completed a robotics fellowship at the Department of Urology, McGill University in Canada. His main interests include basic (biomarkers in prostate cancer) and clinical (focal therapy, minimally invasive techniques) research that has been funded by research grants) in uro-oncology. Guillaume Ploussard is managing editor of World Journal of Urology, section editor of European Urology Today, member of the sub-committee at the EAU section of Oncological Urology, chairman of the YAU-EAU Working Party on prostate cancer and member of the French Cancerology Committe (CC-AFU). He has published more than 150 articles in peer-reviewed journals and received multiple national and international awards for his work.

Courses
Capio Clinique Saint-Jean Languedoc
November 29
5
Seats available
Price /
1 000 €
Masterclass
Capio Clinique Saint-Jean Languedoc
29th November
Seats available
1 000 € / Attendee
Work Experience
Uro-Oncologist
Since 2016 Institut Universitaire du Cancer Toulouse - Oncopole
Senior Urologist
Urology Department Since 2015 Saint Jean Languedoc Hospital, Toulouse
Attending staff – Senior physician
Urology Department 2014 to 2015 Saint-Louis Academic Hospital, APHP Paris 7 University
Clinical Fellow in Robotic Surgery
2013 McGill University, Montreal, Canada
Assistant Professor
Urology Department 2010 to 2012 Saint-Louis Academic Hospital, APHP Paris 7 University
Residency in General Surgery and Urology
2004 to 2010 Assistance Publique – Hôpitaux de Paris
Research Fellow in Onco-Urology
Research Unit Team 7 INSERM 955 “Translational Research in Onco-Urology” 2008 to 2009 Faculty of Medecine, Mondor Academic Hospital
Education
Habilitation à Diriger les Recherches
2014 UPEC Paris XII
Fellowship in Robotic Surgery (clinical fellowship)
2013 McGill University, Montreal (QC), Canada
Board Certification in Oncology
2012 Paris V- René Descartes University
Ph.D. (Doctorat en Sciences) in Cellular and Molecular Biology
2011 UPEC Paris XII
Board Certification in General Surgery
2011 Paris V- René Descartes University
Certification in Laparoscopic Surgery
2011 IRCAD
M.D. (Doctorat en médecine)
2010 Paris V- René Descartes University
Master of Research in Surgical Sciences (Oncology)
2009 UPEC Paris XII University
Certification in Biostatistics
2007 Paris VI – Pierre et Marie Curie university
Pubmed
2017
AR-V7 predicting treatment response in metastasized prostate cancer: has it peaked? World journal of urology Read it here
2017
Does teaching of robotic partial nephrectomy affect renal function and perioperative outcomes? Urologic oncology Read it here
2017
Re: Salvage High-intensity Focused Ultrasound (HIFU) for Locally Recurrent Prostate Cancer After Failed Radiation Therapy: Multi-institutional Analysis of 418 Patients. European urology Read it here
2017
Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes. Urologic oncology Read it here
2017
Focal therapy as primary treatment for localized prostate cancer: definition, needs and future. Future oncology (London, England) Read it here
2017
Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. World journal of urology Read it here
2017
Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk. World journal of urology Read it here
2017
External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients. The Prostate Read it here
2017
Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. European urology Read it here
2017
Kallikreins Panel for Prostate Cancer Aggressiveness Prediction: More Is Not Enough. European urology focus Read it here
2017
[Active surveillance of prostate cancer]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Read it here
2017
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment. European urology focus Read it here
2016
What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer? World journal of urology Read it here
2016
Role of multiparametric magnetic resonance imaging in early detection of prostate cancer. Insights into imaging Read it here
2016
[Castration modalities in prostate cancer: Are they all equal?]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Read it here
2016
Endoscopic description of renal papillary abnormalities in stone disease by flexible ureteroscopy: a proposed classification of severity and type. World journal of urology Read it here
2016
Conditional Disease-free Survival After Radical Prostatectomy: Recurrence Risk Evolution Over Time. Urology Read it here
2016
Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer. BMC urology Read it here
2016
Re: Aquablation - Image Guided Robotically-Assisted Waterjet Ablation of the Prostate: Initial Clinical Experience. European urology Read it here
2016
[Cardiovascular risks with prostate cancer hormonal treatment: rationale for a department of oncocardiology]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Read it here
2016
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery. World journal of urology Read it here
2016
Current practice and access to prostate MR imaging in France. Diagnostic and interventional imaging Read it here
2016
[CCAFU french national guidelines 2016-2018 on prostate cancer]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Read it here
2016
Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy-Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey. European urology focus Read it here
2015
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G. European urology Read it here
2015
Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling. Archivos espanoles de urologia Read it here
2015
Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature. The Journal of urology Read it here
2015
[Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences with cystectomy]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Read it here
2015
Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey. World journal of urology Read it here
2015
Approaches for Initial Prostate Biopsy and Antibiotic Prophylaxis. European urology focus Read it here
2015
Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database. European urology focus Read it here
2015
[Treatments around surgery of prostate cancer and surgery of recurrence]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Read it here
2015
Bladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic Review. PloS one Read it here
2015
Will Multiparametric Magnetic Resonance Imaging-guided Biopsies Replace Systematic Biopsies? European urology focus Read it here
2014
Concomitant high-grade prostatic intraepithelial neoplasia is associated with good prognosis factors and oncologic outcome after radical prostatectomy. Urologia internationalis Read it here
2014
Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. European urology Read it here
2014
Advocacy for renal biopsy based on two cases of mixed epithelial and stromal tumour. Urologia internationalis Read it here
2014
Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy. European urology Read it here
2014
Challenging treatment decision-making in older urologic cancer patients. World journal of urology Read it here
2014
The quest for an optimal definition of prostate-specific antigen failure following radical prostatectomy: the risk of not seeing the forest for the trees. European urology Read it here
2014
Impact of the type of ultrasound probe on prostate cancer detection rate and characterization in patients undergoing MRI-targeted prostate biopsies using cognitive fusion. World journal of urology Read it here
2014
Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. European urology Read it here
2014
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomes. Clinical genitourinary cancer Read it here
2014
Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study. World journal of urology Read it here
2014
Comparisons of the perioperative, functional, and oncologic outcomes after robot-assisted versus pure extraperitoneal laparoscopic radical prostatectomy. European urology Read it here
2013
Triptorelin in the management of prostate cancer. Future oncology (London, England) Read it here
2013
Detailed biopsy pathologic features as predictive factors for initial reclassification in prostate cancer patients eligible for active surveillance. Urologic oncology Read it here
2013
Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS). BJU international Read it here
2013
Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. European urology Read it here
2013
Hepatitis C transmission after prostate biopsy. Case reports in urology Read it here
2013
Extraperitoneal robot-assisted laparoscopic radical prostatectomy: a single-center experience beyond the learning curve. World journal of urology Read it here
2013
Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol. Urologia internationalis Read it here
2013
Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial. BJU international Read it here
2013
[Prostate brachytherapy: indications and outcomes]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Read it here
2013
Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomy. The Journal of urology Read it here
2013
Patient selection and pathological outcomes using currently available active surveillance criteria. BJU international Read it here
2013
Prostate biopsies: let's move forward. European urology Read it here
2013
Contemporary pathologic characteristics and oncologic outcomes of prostate cancers missed by 6- and 12-core biopsy and diagnosed with a 21-core biopsy protocol. World journal of urology Read it here
2012
How much should we pursue an elevated prostate specific antigen? The Journal of urology Read it here
2012
Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy. Urology Read it here
2012
[5 alpha-reductase inhibitors and prostate cancer: a statement of the Committee of Cancerology of the French Association of Urology]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie Read it here
2012
Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study. Urology Read it here
2012
Anastomotic stricture after minimally invasive radical prostatectomy: what should be expected from the Van Velthoven single-knot running suture? Journal of endourology Read it here
2012
Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy. The Canadian journal of urology Read it here
2012
Radical prostatectomy as primary treatment of high-risk prostate cancer. Current urology reports Read it here
2012
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy. BJU international Read it here
Professional Associations
French Association of Urology (AFU)
Member
European Association of Urology (EAU)
Member
European Society of Onco-Urology (ESOU)
Member
Société Internationale d’Urologie (SIU)
Member
Prostate Cancer Committee of the French Association of Urology (CC-AFU)
Member
Prostate Cancer Committee of the Young Academic Urologist Working Party
Chairman
French Urology-Geriatrics Interdisciplinary Group (AFU, SoFOG)
Member
Young Urologist Office (YOU-EAU)
Board Member
Honors
First Prize for Best Scientific Production in BJU International : John Blandy Award
2012
First Prize for Best Clinical Article in European Urology : Resident Corner Award
2010
First Prize for Best Research Investigation : “Chirurgiens de l’Avenir” Award
2009
First Prize for Best Research Investigation : Alexandre Joël Award
2009
Personal info
Overview
Courses
Work Experience
Education
Pubmed
Professional associations
Honors

Javascript Is Disabled

Javascript seems to be disabled on your browser. Invivox.com is not usable without Javascript enabled.

To enable Javascript click here

Javascript a l'air d'être désactivé dans votre navigateur. Invivox.com n'est pas utilisable sans javascript.

Pour activer Javascript, cliquer ici